These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 6467174)

  • 21. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
    Hill BT; Whelan RD
    J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys.
    Sethi VS; Surratt P; Spurr CL
    Cancer Chemother Pharmacol; 1984; 12(1):31-5. PubMed ID: 6690071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation and release of vinblastine and vincristine by HeLa cells: light microscopic, cinematographic, and biochemical study.
    Lengsfeld AM; Dietrich J; Schultze-Maurer B
    Cancer Res; 1982 Sep; 42(9):3798-805. PubMed ID: 7105045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on axonal fibrillar organelles in vitro.
    Donoso JA; Green LS; Heller-Bettinger IE; Samson FE
    Cancer Res; 1977 May; 37(5):1401-7. PubMed ID: 558047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
    Nelson RL
    Med Pediatr Oncol; 1982; 10(2):115-27. PubMed ID: 7070351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension.
    Zhou XJ; Placidi M; Rahmani R
    Anticancer Res; 1994; 14(3A):1017-22. PubMed ID: 8074443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
    Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
    J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological properties of a new alpha-aminophosphonic acid derivative of vinblastine.
    Pierré A; Lavielle G; Hautefaye P; Seurre G; Leonce S; Saint-Dizier D; Boutin JA; Cudennec CA
    Anticancer Res; 1990; 10(1):139-44. PubMed ID: 2334119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
    Houghton JA; Williams LG; Torrance PM; Houghton PJ
    Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinblastine, Vincristine and Vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro.
    Mareel MM; Storme GA; De Bruyne GK; Van Cauwenberge RM
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):199-210. PubMed ID: 7201395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
    Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental in vivo cross-resistance of vinca alkaloid drugs.
    Maral R; Bourut C; Chenu E; Mathe G
    Cancer Chemother Pharmacol; 1981; 5(3):197-9. PubMed ID: 7296754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B16 and CLS91 mouse melanoma cells susceptibility to apoptosis after vincristin treatment in vitro.
    Olszewska-Słonina D; Drewa T; Styczyński J; Olszewski K; Musiałkiewicz D
    Acta Pol Pharm; 2004; 61(2):113-21. PubMed ID: 15493293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.